SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venmax Drugs & Pharmaceuticals informs about statement of investor complaints

21 Jul 2017 Evaluate

Venmax Drugs & Pharmaceuticals has informed about the Statement of Investor Complaints for the Quarter ended 30th June 2017 under regulation 13 (3) of the SEBI (LODR) Regulation 2015.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

26.05 1.39 (5.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×